4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine

CAS: 6632-68-4

Ref. 3D-FA07965

Informação sobre produto

• Nome: 4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine
• Sinónimos: 6-AMINO-1,3-DIMETHYL-5-NITROSOURACIL, 1,3-Dimethyl-4-amino-5-nitrosouracil, 2,4(1H,3H)-Pyrimidinedione, 6-amino-1,3-dimethyl-5-nitroso-, 4-Amino-1,3-dimethyl-5-nitrosouracil, 6-Amino-1,3-dimethyl-5-nitroso-2,4(1H,3H)-pyrimidinedione, 6-Amino-1,3-dimethyl-5-nitrosopyrimidine-2,4-dione, 6-Amino-1,3-dimethyl-5-nitrosouracil, 8-[(dimethylamino)methyl]-7-hydroxy-3-(naphthalen-2-yloxy)-2-(trifluoromethyl)-4H-chromen-4-one, NSC 11775, NSC 41585, NSC 41832, NSC 42306, NSC 677508, Uracil, 6-amino-1,3-dimethyl-5-nitroso-

Descrição

4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine is a monoclonal antibody that binds to cancer cells. It has been shown to be effective in the treatment of leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma. The binding of 4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine to cancer cells is due to the formation of a coordination geometry between the copper complex and the nitrogen atoms on the amino group. This drug has been shown to inhibit tumor growth by blocking the synthesis of DNA and RNA, which are key components in cell division. 4AADNP also inhibits cancer cells' ability to uptake glucose by inhibiting cellular glucose transporters. The binding affinity of 4AADNP for cancer cells is higher than for normal cells because cancer cells have more receptors for this drug

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 184.15 g/mol
• Fórmula: C₆H₈N₄O₃
• Pureza: Min. 95%